Seca Ana M L, Grigore Alice, Pinto Diana C G A, Silva Artur M S
DCTD, University of Azores, 9501-801 Ponta Delgada, Portugal; Chemistry Department & QOPNA, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.
Department of Pharmaceutical Biotechnologies, National Institute of Chemical-Pharmaceutical R&D, 112 Vitan Av., Bucharest, Romania.
J Ethnopharmacol. 2014 Jun 11;154(2):286-310. doi: 10.1016/j.jep.2014.04.010. Epub 2014 Apr 19.
The genus Inula comprises more than one hundred species widespread in temperate regions of Europe and Asia. Uses of this genus as herbal medicines have been first recorded by the Greek and Roman ancient physicians. In the Chinese Pharmacopoeia, from the 20 Inula spp. distributed in China, three are used as Traditional Chinese medicines, named Tumuxiang, Xuanfuhua and Jinfeicao. These medicines are used as expectorants, antitussives, diaphoretics, antiemetics, and bactericides. Moreover, Inula helenium L. which is mentioned in Minoan, Mycenaean, Egyptian/Assyrian pharmacotherapy and Chilandar Medical Codex, is good to treat neoplasm, wound, freckles and dandruff. Many other Inula spp. are used in Ayurvedic and Tibetan traditional medicinal systems for the treatment of diseases such as bronchitis, diabetes, fever, hypertension and several types of inflammation. This review is a critical evaluation of the published data on the more relevant ethnopharmacological and medicinal uses of Inula spp. and on their metabolites biological activities. This study allows the identification of the ethnopharmacological knowledge of this genus and will provide insight into the emerging pharmacological applications of Inula spp. facilitating the prioritirization of future investigations. The corroboration of the ethnopharmacological applications described in the literature with proved biological activities of Inula spp. secondary metabolites will also be explored.
The major scientific databases including ScienceDirect, Medline, Scopus and Web of Science were queried for information on the genus Inula using various keyword combinations, more than 180 papers and patents related to the genus Inula were consulted. The International Plant Name Index was also used to confirm the species names.
Although the benefits of Inula spp. are known for centuries, there are insufficient scientific studies to certify it. Most of the patents are registered by Chinese researchers, proving the traditional use of these plants in their country. Although a total of sixteen Inula species were reported in the literature to have ethnopharmacological applications, the species Inula cappa (Buch.-Ham. ex D.Don) DC., Inula racemosa Hook.f., Inula viscosa (L.) Aiton [actually the accepted name is Dittrichia viscosa (L.) Greuter], Inula helenium, Inula britannica L. and Inula japonica Thunb. are the most frequently cited ones since their ethnopharmacological applications are vast. They are used to treat a large spectrum of disorders, mainly respiratory, digestive, inflammatory, dermatological, cancer and microbial diseases. Fifteen Inula spp. crude extracts were investigated and showed interesting biological activities. From these, only 7 involved extracts of the reported spp. used in traditional medicine and 6 of these were studied to isolate the bioactive compounds. Furthermore, 90 bioactive compounds were isolated from 16 Inula spp. The characteristic compounds of the genus, sesquiterpene lactones, are involved in a network of biological effects, and in consequence, the majority of the experimental studies are focused on these products, especially on their cytotoxic and anti-inflammatory activities. The review shows the chemical composition of the genus Inula and presents the pharmacological effects proved by in vitro and in vivo experiments, namely the cytotoxic, anti-inflammatory (with focus on nitric oxide, arachidonic acid and NF-κB pathways), antimicrobial, antidiabetic and insecticidal activities.
Although there are ca. 100 species in the genus Inula, only a few species have been investigated so far. Eight of the sixteen Inula spp. with ethnopharmacological application had been subjected to biological evaluations and/or phytochemical studies. Despite Inula royleana DC. and Inula obtusifolia A. Kerner are being used in traditional medicine, as far as we are aware, these species were not subjected to phytochemical or pharmacological studies. The biological activities exhibited by the compounds isolated from Inula spp., mainly anti-inflammatory and cytotoxic, support some of the described ethnopharmacological applications. Sesquiterpene lactone derivatives were identified as the most studied class, being britannilactone derivatives the most active ones and present high potential as anti-inflammatory drugs, although, their pharmacological effects, dose-response relationship and toxicological investigations to assess potential for acute or chronic adverse effects should be further investigated. The experimental results are promising, but the precise mechanism of action, the compound or extract toxicity, and the dose to be administrated for an optimal effect need to be investigated. Also human trials (some preclinical studies proved to be remarkable) should be further investigated. The genus Inula comprises species useful not only in medicine but also in other domains which makes it a high value-added plant.
旋覆花属包含100多个物种,广泛分布于欧洲和亚洲的温带地区。该属植物作为草药的用途最早由希腊和罗马古代医生记录。在中国药典中,分布于中国的20种旋覆花属植物中,有3种被用作中药,分别名为土木香、旋覆花和金沸草。这些药物用作祛痰剂、止咳剂、发汗剂、止吐剂和杀菌剂。此外,在米诺斯、迈锡尼、埃及/亚述药物疗法和奇兰达尔医学法典中提到的土木香,对治疗肿瘤、伤口、雀斑和头皮屑有好处。许多其他旋覆花属植物在阿育吠陀和藏药传统医学体系中用于治疗支气管炎、糖尿病、发热、高血压和几种炎症等疾病。本综述是对已发表的关于旋覆花属植物更相关的民族药理学和药用用途及其代谢产物生物活性数据的批判性评价。这项研究有助于确定该属的民族药理学知识,并将深入了解旋覆花属植物新出现的药理学应用,为未来研究的优先级提供便利。还将探讨文献中描述的民族药理学应用与旋覆花属植物次生代谢产物已证实的生物活性之间的相互印证。
使用各种关键词组合在包括ScienceDirect、Medline、Scopus和Web of Science在内的主要科学数据库中查询有关旋覆花属的信息,查阅了180多篇与旋覆花属相关的论文和专利。国际植物名称索引也用于确认物种名称。
尽管旋覆花属植物的益处已为人所知数百年,但尚无足够的科学研究来证实。大多数专利由中国研究人员注册,证明了这些植物在其国家的传统用途。尽管文献中总共报道了16种旋覆花属植物具有民族药理学应用,但卡氏旋覆花、总状花旋覆花、粘毛旋覆花(实际上公认的名称是粘毛迪特里希菊)、土木香、欧亚旋覆花和日本旋覆花是最常被引用的,因为它们的民族药理学应用广泛。它们用于治疗多种疾病,主要是呼吸道、消化、炎症、皮肤病、癌症和微生物疾病。对15种旋覆花属植物的粗提物进行了研究,显示出有趣的生物活性。其中,只有7种涉及传统医学中使用的报道物种的提取物,并且对其中6种进行了研究以分离生物活性化合物。此外,从16种旋覆花属植物中分离出90种生物活性化合物。该属的特征化合物倍半萜内酯参与了生物效应网络,因此,大多数实验研究都集中在这些产物上,尤其是它们的细胞毒性和抗炎活性。该综述展示了旋覆花属的化学成分,并呈现了体外和体内实验证明的药理作用,即细胞毒性、抗炎(重点关注一氧化氮、花生四烯酸和NF-κB途径)、抗菌、抗糖尿病和杀虫活性。
尽管旋覆花属约有100个物种,但到目前为止仅对少数物种进行了研究。16种具有民族药理学应用的旋覆花属植物中有8种已进行了生物学评价和/或植物化学研究。尽管罗氏旋覆花和钝叶旋覆花被用于传统医学,但据我们所知,这些物种尚未进行植物化学或药理学研究。从旋覆花属植物中分离出的化合物表现出的生物活性,主要是抗炎和细胞毒性,支持了一些所描述的民族药理学应用。倍半萜内酯衍生物被确定为研究最多的类别,不列颠内酯衍生物是最具活性的,作为抗炎药物具有很高的潜力,尽管它们的药理作用、剂量反应关系以及评估急性或慢性不良反应可能性的毒理学研究仍需进一步研究。实验结果很有前景,但作用的精确机制、化合物或提取物的毒性以及为达到最佳效果所需的给药剂量都需要研究。此外,人体试验(一些临床前研究证明很显著)也应进一步研究。旋覆花属包含不仅在医学上而且在其他领域有用的物种,这使其成为一种高附加值植物。